• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Silo Pharma, Inc.

< Previous 1 2 3 Next >
News headline image
Silo Pharma Announces Pipeline Prioritization for 2024 Targeting Mental Health, Chronic Pain, and Neurology
February 01, 2024
From Silo Pharma, Inc.
Via GlobeNewswire
Tickers SILO
News headline image
Silo Pharma Announces Positive Results in Alzheimer’s Disease Study
January 24, 2024
From Silo Pharma, Inc.
Via GlobeNewswire
Tickers SILO
News headline image
Silo Pharma Successfully Completes First Phase of Dose-Ranging Study of SPC-15 an Intranasal Treatment for PTSD
January 04, 2024
From Silo Pharma, Inc.
Via GlobeNewswire
Tickers SILO
News headline image
Silo Pharma and Partner Receive Regulatory Approval to Begin Development of Ketamine Implant for Fibromyalgia
December 28, 2023
From Silo Pharma, Inc.
Via GlobeNewswire
Tickers SILO
News headline image
Silo Pharma Enters into Exclusive License Agreement with Medspray Pharma BV for Intranasal Technology used in SPC-15 Treatment for PTSD
November 21, 2023
From Silo Pharma, Inc.
Via GlobeNewswire
Tickers SILO
News headline image
Silo Pharma to Initiate Dose-Ranging Study of Novel Intranasal Therapeutic SPC-15 for the Treatment of PTSD
November 08, 2023
From Silo Pharma, Inc.
Via GlobeNewswire
Tickers SILO
News headline image
Silo Pharma’s SPU-21 Peptide Shows Positive Results Against Rheumatoid Arthritis
October 16, 2023
From Silo Pharma, Inc.
Via GlobeNewswire
Tickers SILO
News headline image
Silo Pharma Initiates Human Factor Study of SPC-15 for the Treatment of PTSD
October 11, 2023
From Silo Pharma, Inc.
Via GlobeNewswire
Tickers SILO
News headline image
Silo Pharma Announces Positive Data on SPC-15 for PTSD and Prepares to File Pre-Investigational New Drug (IND) Application with FDA
September 20, 2023
From Silo Pharma, Inc.
Via GlobeNewswire
Tickers SILO
News headline image
Silo Pharma Initiates Feasibility Study of SPC-15 Novel Intranasal Formulation for PTSD
September 12, 2023
From Silo Pharma, Inc.
Via GlobeNewswire
Tickers SILO
News headline image
Silo Pharma Engages Clarivate for Intellectual Property and Patent Management
August 10, 2023
From Silo Pharma, Inc.
Via GlobeNewswire
Tickers SILO
News headline image
Silo Pharma Reaches Positive Milestone with Nasal Formulation of SPC-15 For Anxiety, PTSD, and Stress-Related Disorders
August 08, 2023
From Silo Pharma, Inc.
Via GlobeNewswire
Tickers SILO
News headline image
Silo Pharma’s SPU-21 Treatment for Autoimmune Disease Awarded U.S. Patent
June 21, 2023
From Silo Pharma, Inc.
Via GlobeNewswire
Tickers SILO
News headline image
Silo Pharma Signs Agreement to Develop First-in-Class Ketamine Implant Therapeutic
June 13, 2023
From Silo Pharma, Inc.
Via GlobeNewswire
Tickers SILO
News headline image
Silo Pharma Announces Participation on Webull Corporate Communications Service Platform
June 02, 2023
From Silo Pharma, Inc.
Via GlobeNewswire
Tickers SILO
News headline image
Silo Pharma Commences Study of Novel Joint Homing Peptide SPU-21
May 30, 2023
From Silo Pharma, Inc.
Via GlobeNewswire
Tickers SILO
News headline image
Silo Pharma’s SPC-15 Awarded U.S. Patent Protecting Ongoing R&D of Therapeutic for Stress-Induced Affective Disorder and Alzheimer’s Disease
May 09, 2023
From Silo Pharma, Inc.
Via GlobeNewswire
Tickers SILO
News headline image
Silo Pharma to Present at Psychedelic Drug Development Conference
April 24, 2023
From Silo Pharma, Inc.
Via GlobeNewswire
Tickers SILO
News headline image
Silo Pharma Commences Formulation for SPC-15 Targeting Anxiety and PTSD Stress-Related Disorders
April 19, 2023
From Silo Pharma, Inc.
Via GlobeNewswire
Tickers SILO
News headline image
Silo Pharma Announces filing of Patent for Treatment of Fibromyalgia
March 27, 2023
From Silo Pharma, Inc.
Via GlobeNewswire
Tickers SILO
News headline image
Silo Pharma Announces Positive Results from IND-Enabling Study of SP-26 for Fibromyalgia
March 15, 2023
From Silo Pharma, Inc.
Via GlobeNewswire
Tickers SILO
News headline image
Silo Pharma Announces Filing of Patent for Treatment of Alzheimer’s
February 13, 2023
From Silo Pharma, Inc.
Via GlobeNewswire
Tickers SILO
News headline image
Silo Pharma Announces Expansion of Intellectual Property Portfolio
February 02, 2023
From Silo Pharma, Inc.
Via GlobeNewswire
Tickers SILO
News headline image
Silo Pharma Announces Stock Repurchase Program
January 31, 2023
From Silo Pharma, Inc.
Via GlobeNewswire
Tickers SILO
News headline image
Silo Pharma Advances Clinical Study Analyzing Effects of Psilocybin on Inflammation
January 10, 2023
From Silo Pharma, Inc.
Via GlobeNewswire
Tickers SILO
News headline image
Silo Pharma Announces Positive Study Results of SPU- 21 for Arthritis
December 30, 2022
From Silo Pharma, Inc.
Via GlobeNewswire
Tickers SILO
News headline image
Silo Pharma Issues Letter to Shareholders Detailing Progress on Pipeline Assets Combining Traditional Therapeutics with Psychedelic Medicine
December 01, 2022
From Silo Pharma, Inc.
Via GlobeNewswire
Tickers SILO
News headline image
Silo Pharma Initiates Study of Novel Joint Homing Peptide in Human Tissue
November 21, 2022
From Silo Pharma, Inc.
Via GlobeNewswire
Tickers SILO
News headline image
Silo Pharma Achieves New Milestone for SP-26 Therapeutic -Initiates IND Enabling Study of Topical Ketamine Formulation
November 11, 2022
From Silo Pharma, Inc.
Via GlobeNewswire
Tickers SILO
News headline image
Silo Pharma to Discuss Mainstream Pharma and Psychedelics at Wonderland Miami Conference
October 26, 2022
From Silo Pharma, Inc.
Via GlobeNewswire
Tickers SILO
< Previous 1 2 3 Next >
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap